-+ 0.00%
-+ 0.00%
-+ 0.00%

AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate

Benzinga·08/12/2026 20:34:38
Listen to the news
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of $(0.60) per share from the same period last year.